Familial steroid-resistant nephrotic syndrome with sensorineural deafness
fuh-MIL-ee-ul ste-roid ree-ZIS-tunt nef-ROT-ik SIN-drohm with sen-sor-ee-NOOR-al DEF-ness
Also known as: COQ6 nephropathy, Coenzyme Q10 deficiency with deafness
At a Glance
What is Familial steroid-resistant nephrotic syndrome with sensorineural deafness?
Familial steroid-resistant nephrotic syndrome with sensorineural deafness is a rare genetic disorder that primarily affects the kidneys and ears. It is caused by mutations in the COQ6 gene, which is important for producing coenzyme Q10, a vital component in cellular energy production. The condition leads to nephrotic syndrome, where the kidneys leak protein into the urine, and sensorineural deafness, which affects hearing. Symptoms often begin in childhood, with early signs including swelling, fatigue, and hearing loss. Over time, kidney function may decline, leading to chronic kidney disease. Early diagnosis is crucial to manage symptoms and slow disease progression. The disorder can significantly impact family life, requiring frequent medical visits and lifestyle adjustments. Prognosis varies, but many individuals may require kidney transplantation or dialysis. Daily life can be challenging, with the need for hearing aids and dietary restrictions. Supportive therapies and coenzyme Q10 supplementation may help manage symptoms. Families often need to coordinate care among multiple specialists. Genetic counseling is recommended for affected families to understand inheritance patterns and risks.
Familial steroid-resistant nephrotic syndrome with sensorineural deafness Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Nephrotic syndrome manifests as proteinuria, hypoalbuminemia, and edema. It is caused by damage to the glomeruli, which are the kidney's filtering units, often due to genetic mutations affecting coenzyme Q10. Over time, this can progress to chronic kidney disease if not managed effectively. Daily life is impacted by fatigue and swelling, but management includes medications like ACE inhibitors and dietary modifications to reduce symptoms.
Sensorineural deafness presents as a gradual loss of hearing, typically affecting high frequencies first. It results from damage to the inner ear or the auditory nerve, often linked to genetic mutations affecting mitochondrial function. The hearing loss can worsen over time, leading to significant communication challenges. Hearing aids or cochlear implants, along with speech therapy, can help improve quality of life.
Optic atrophy is characterized by a gradual loss of vision due to the degeneration of the optic nerve. This condition is often associated with mitochondrial dysfunction, which impairs the nerve's ability to transmit visual information. Over time, it can lead to significant visual impairment or blindness. Regular ophthalmologic evaluations and supportive therapies, such as visual aids, can help manage the impact on daily activities.
Common
Fatigue is a persistent feeling of tiredness or exhaustion that is not relieved by rest. It is often due to the body's increased energy demands and reduced kidney function, leading to an accumulation of waste products in the blood. Over time, fatigue can become more pronounced and interfere with daily activities. Management includes addressing the underlying kidney disease and ensuring adequate rest and nutrition.
Edema is the swelling of tissues, particularly in the legs, ankles, and around the eyes, due to fluid retention. It occurs when the kidneys are unable to maintain the balance of salt and water, often due to protein loss in the urine. If untreated, edema can lead to discomfort and mobility issues. Diuretics and dietary changes can help manage fluid retention and reduce swelling.
Hypertension, or high blood pressure, often develops as a result of kidney dysfunction. The kidneys play a crucial role in regulating blood pressure, and their impairment can lead to increased vascular resistance. Over time, uncontrolled hypertension can cause further damage to the kidneys and cardiovascular system. Blood pressure management through lifestyle changes and medications is essential to prevent complications.
Less Common
Growth retardation is a slower than normal growth rate in children, often observed in those with chronic kidney disease. It results from a combination of nutritional deficiencies, hormonal imbalances, and the body's increased energy demands. Without intervention, growth retardation can lead to short stature and developmental delays. Nutritional support and growth hormone therapy can help improve growth outcomes.
Muscle weakness is a reduction in muscle strength, often experienced as difficulty in performing physical tasks. It can be caused by electrolyte imbalances and reduced energy production due to kidney dysfunction. Over time, muscle weakness can lead to decreased physical activity and increased risk of falls. Physical therapy and nutritional support can help improve muscle strength and function.
What Causes Familial steroid-resistant nephrotic syndrome with sensorineural deafness?
Familial steroid-resistant nephrotic syndrome with sensorineural deafness is primarily caused by mutations in the COQ6 gene, located on chromosome 14q24.3. The COQ6 gene encodes a monooxygenase enzyme that plays a crucial role in the biosynthesis of coenzyme Q10 (CoQ10), an essential component of the mitochondrial electron transport chain. Mutations in COQ6 can lead to a defective enzyme, impairing CoQ10 production and disrupting mitochondrial function. This disruption results in decreased ATP production and increased oxidative stress within the cell. Mitochondrial dysfunction can lead to apoptosis or necrosis of renal podocytes and cochlear cells, causing nephrotic syndrome and sensorineural deafness. The loss of podocytes compromises the glomerular filtration barrier, leading to proteinuria and progressive kidney damage. In the cochlea, cell death affects the hair cells, resulting in hearing loss. Neuroinflammation may exacerbate tissue damage, as immune cells infiltrate and release pro-inflammatory cytokines. White matter degeneration might occur due to energy deficits and oxidative damage in neural tissues. Symptoms appear in a specific pattern due to the differential energy demands and vulnerability of kidney and cochlear cells to oxidative stress. Variability in disease severity among patients can be attributed to the type of mutation, residual enzyme activity, and potential compensatory mechanisms. Other genetic or environmental factors may also influence the clinical phenotype. The presence of optic atrophy in some patients suggests that retinal ganglion cells are similarly affected by mitochondrial dysfunction. Understanding the precise molecular mechanisms can aid in developing targeted therapies to mitigate the effects of these mutations.
How is Familial steroid-resistant nephrotic syndrome with sensorineural deafness Diagnosed?
Typical age of diagnosis: Diagnosis typically occurs in childhood, often between the ages of 2 and 10 years, when symptoms such as proteinuria and hearing loss become apparent. Early diagnosis is crucial for managing the condition and preventing progression to kidney failure.
Clinicians look for signs of nephrotic syndrome, such as edema and proteinuria, and sensorineural hearing loss. A detailed family history is important to identify any hereditary patterns. Physical examination may reveal swelling, particularly in the face and extremities, and hearing tests may show deficits. This step helps to determine the likelihood of a genetic condition and guides further testing.
Renal ultrasound is commonly used to assess kidney size and structure. Specific abnormalities such as enlarged kidneys or cysts may be visible, supporting the diagnosis of nephrotic syndrome. Imaging findings help confirm the diagnosis by excluding other causes of kidney disease, such as congenital abnormalities. Differential diagnoses like obstructive uropathy or tumors are also excluded through imaging.
Urinalysis is ordered to detect proteinuria and hematuria, while blood tests measure kidney function and electrolyte levels. Biomarkers such as low serum albumin and elevated cholesterol are sought. Abnormal results include significant proteinuria and hypoalbuminemia, indicating nephrotic syndrome. These results guide the decision to proceed with genetic testing and potential biopsy.
Genetic testing involves sequencing the COQ6 gene and other related genes. Mutations such as missense or nonsense variants are commonly found. A positive result confirms the diagnosis of familial steroid-resistant nephrotic syndrome with sensorineural deafness. Genetic results are crucial for family counseling and assessing the risk for other family members.
Familial steroid-resistant nephrotic syndrome with sensorineural deafness Treatment Options
Coenzyme Q10 is a lipid-soluble antioxidant that plays a crucial role in mitochondrial electron transport. It is used to improve mitochondrial function and reduce oxidative stress in affected patients. Clinical evidence suggests that CoQ10 supplementation can ameliorate renal symptoms and stabilize hearing loss. However, the efficacy varies among individuals, and side effects may include gastrointestinal discomfort. Long-term benefits and optimal dosing require further study.
Techniques include auditory training and the use of hearing aids to improve communication skills. The therapeutic goal is to enhance auditory perception and speech understanding. Sessions are typically conducted weekly and last for 30-60 minutes each. Measurable outcomes include improved speech recognition scores and better quality of life. Long-term benefits include enhanced social interaction and educational performance.
Indicated for patients with end-stage renal disease due to nephrotic syndrome. The procedure involves replacing the diseased kidney with a healthy donor kidney. Expected benefits include restored kidney function and improved quality of life. Surgical risks include rejection, infection, and complications from immunosuppressive therapy. Post-operative care requires lifelong monitoring and medication adherence.
The care team includes nephrologists, audiologists, genetic counselors, and dietitians. Interventions focus on managing symptoms, optimizing nutrition, and providing hearing support. Psychosocial support strategies include counseling and support groups for patients and families. Family education covers disease management, treatment options, and genetic implications. Long-term monitoring involves regular follow-ups to assess disease progression and treatment efficacy.
When to See a Doctor for Familial steroid-resistant nephrotic syndrome with sensorineural deafness
- Severe swelling in the legs or abdomen — this could indicate worsening kidney function and requires immediate medical attention.
- Sudden loss of hearing — this may suggest progression of sensorineural deafness and needs urgent evaluation.
- Difficulty breathing or chest pain — these symptoms could be signs of fluid overload or heart complications, necessitating emergency care.
- Persistent fatigue — this may indicate anemia or kidney dysfunction, and a healthcare provider should assess it.
- Frequent headaches — could be related to high blood pressure or electrolyte imbalances, requiring medical advice.
- Reduced urine output — may suggest declining kidney function and should be evaluated by a doctor.
- Mild swelling in the ankles — monitor for changes and discuss with a doctor if it worsens.
- Occasional ringing in the ears — keep track of frequency and intensity, and inform your healthcare provider.
Familial steroid-resistant nephrotic syndrome with sensorineural deafness — Frequently Asked Questions
Is this condition hereditary?
Familial steroid-resistant nephrotic syndrome with sensorineural deafness is typically inherited in an autosomal recessive pattern. This means both parents must carry one copy of the mutated gene to pass it to their children. De novo mutations are rare but possible. Carriers usually do not show symptoms but can pass the mutation to offspring. Genetic counseling is recommended for affected families to understand risks and implications.
What is the life expectancy for someone with this condition?
Life expectancy varies depending on the age of onset and severity of symptoms. Early diagnosis and treatment can improve outcomes significantly. Kidney failure and associated complications are common causes of mortality. Treatment, including Coenzyme Q10 supplementation, can enhance quality of life and potentially extend survival. Realistic expectations should include ongoing medical management and lifestyle adaptations.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves a combination of clinical evaluation, genetic testing, and audiological assessments. The time from first symptoms to diagnosis can vary, often taking several months. Nephrologists, geneticists, and audiologists are typically involved in the diagnostic process. Delays often occur due to the rarity of the condition and overlapping symptoms with other diseases. Genetic testing confirming mutations in genes like COQ6 is definitive for diagnosis.
Are there any new treatments or clinical trials available?
Research is ongoing into gene therapy and novel pharmacological interventions for this condition. Coenzyme Q10 supplementation remains a promising treatment option. Clinical trials can be found on ClinicalTrials.gov by searching for nephrotic syndrome or COQ6-related studies. Patients should discuss potential trial participation with their healthcare provider. New treatments are in development, but widespread availability may take several years.
How does this condition affect daily life and activities?
The condition can impact mobility due to swelling and fatigue, affecting self-care and daily tasks. Educational accommodations may be necessary due to hearing impairments. Social and emotional challenges include coping with chronic illness and potential isolation. Family members often face increased caregiving responsibilities. Supportive therapies and adaptive devices can significantly improve quality of life.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Variation of the clinical spectrum and genotype-phenotype associations in Coenzyme Q10 deficiency associated glomerulopathy.
Drovandi S, Lipska-Ziętkiewicz BS, Ozaltin F et al. · Kidney Int · 2022 · PMID: 35483523
- 2.COQ6 mutation in patients with nephrotic syndrome, sensorineural deafness, and optic atrophy.
Justine Perrin R, Rousset-Rouvière C, Garaix F et al. · JIMD Rep · 2020 · PMID: 32685349
- 3.Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children.
Vivante A, Chacham OS, Shril S et al. · Pediatr Nephrol · 2019 · PMID: 31001663
- 4.COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness.
Heeringa SF, Chernin G, Chaki M et al. · J Clin Invest · 2011 · PMID: 21540551
- 5.Glomerular involvement in children with H syndrome.
David O, Geylis M, Kristal E et al. · Pediatr Nephrol · 2021 · PMID: 33387019
- 6.Primary coenzyme Q10 Deficiency-6 (COQ10D6): Two siblings with variable expressivity of the renal phenotype.
Yuruk Yildirim Z, Toksoy G, Uyguner O et al. · Eur J Med Genet · 2020 · PMID: 30682496
- 7.[Coenzyme Q(10) treatment for one child with COQ6 gene mutation induced nephrotic syndrome and literature review].
Cao Q, Li GM, Xu H et al. · Zhonghua Er Ke Za Zhi · 2017 · PMID: 28173653
- 8.Effects of CoQ10 Replacement Therapy on the Audiological Characteristics of Pediatric Patients with COQ6 Variants.
Nam DW, Park SS, Lee SM et al. · Biomed Res Int · 2022 · PMID: 36124066
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-24